COVID-19 Policy Resources
(Updated February 26, 2021)
The following resources are intended to help hematology professionals navigate the complex and fast-changing COVID-19 policy landscape. The list will be updated frequently as more resources become available.
Please visit hematology.org/COVID-19 to explore the full list of resources for hematologists navigating the COVID-19 public health crisis, and visit hematology.org/advocacy for information on ASH's efforts across a range of policy subjects related to hematology.
Available Documents
- Action Alerts to Contact Congress
- ASH Statement on FDA's Updated Blood Donor Eligibility Guidelines
- ASH/SCDAA Joint Letter to Blood Groups on Impact and Management of Blood Shortages on Sickle Cell Disease
- ASH Summary: NIH Provides Guidance on Grants, Operations During COVID-19 Response
- ASH Summary of Telehealth and Licensure Rules and Regulations
- ASH Summary of Coronavirus Aid, Relief and Economic Security (CARES) Act
- CMS Issues COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers
- CMS Issues Rule Outlining Additional Regulatory Changes in Response to COVID-19
- Contact Congress About the Urgent Need for Safe and Ongoing Blood Donations During COVID-19
- ASH Webinar on the Use of Convalescent Plasma During COVID-19
- Informational Webinar on Telehealth During COVID-19
- Partner Society and Coalition Sign-On Letters